Serum and urine 1H NMR-based metabolomics in the diagnosis of selected thyroid diseases.

about

Metabolomics for Prediction of Relapse in Graves' Disease: Observational Pilot Study

P2860

Q58606262-75A1B320-2195-43E4-BC0C-69D9DF69A11C

P2860

Serum and urine 1H NMR-based metabolomics in the diagnosis of selected thyroid diseases.

Item

http://www.wikidata.org/entity/Q38613316

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Serum and urine 1H NMR-based metabolomics in the diagnosis of selected thyroid diseases.

@en

type

Item

label

Serum and urine 1H NMR-based metabolomics in the diagnosis of selected thyroid diseases.

@en

prefLabel

Serum and urine 1H NMR-based metabolomics in the diagnosis of selected thyroid diseases.

@en

P1476

Serum and urine 1H NMR-based metabolomics in the diagnosis of selected thyroid diseases.

@en

P2093

Adam Zabek

http://www.w3.org/2001/XMLSchema#string

Dorota Pawelka

http://www.w3.org/2001/XMLSchema#string

Mateusz Glod

http://www.w3.org/2001/XMLSchema#string

Piotr Mlynarz

http://www.w3.org/2001/XMLSchema#string

Waldemar Balcerzak

http://www.w3.org/2001/XMLSchema#string

P2860

Links between metabolism and cancer

Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections.

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

Contemporary diagnostic approach to the thyroid nodule.

Application of immunohistochemistry to thyroid neoplasms.

RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers.

Molecular diagnostics of thyroid tumors.

Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference.

The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis.

Metabolic fingerprinting as a diagnostic tool.

P2888

s41598-017-09203-3

P304

9108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-09203-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stanislaw Deja

Tomasz Dawiskiba

Wojciech Wojtowicz

P577

2017-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091260115

http://www.w3.org/2001/XMLSchema#string

P698

28831094

http://www.w3.org/2001/XMLSchema#string

P932

5567318

http://www.w3.org/2001/XMLSchema#string

Serum and urine 1H NMR-based metabolomics in the diagnosis of selected thyroid diseases.

about

P2860

P2860

Serum and urine 1H NMR-based metabolomics in the diagnosis of selected thyroid diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932